Methylation of TIMP3 in esophageal squamous cell carcinoma

被引:14
作者
Smith, Eric [1 ]
De Young, Neville J.
Tian, Zi-Qiang [2 ]
Caruso, Maria [3 ]
Ruszkiewicz, Andrew R. [3 ]
Liu, Jun-Feng [2 ]
Jamieson, Glyn G.
Drew, Paul A. [4 ]
机构
[1] Univ Adelaide, Sch Med, Fac Hlth Sci, Discipline Surg,Royal Adelaide Hosp, Adelaide, SA 5005, Australia
[2] Hebei Med Univ, Hosp 4, Dept Thorac Surg, Shijiazhuang, Hebei Province, Peoples R China
[3] Inst Med & Vet Sci, Div Tissue Pathol, Adelaide, SA 5000, Australia
[4] Flinders Univ S Australia, Sch Nursing & Midwifery, Bedford Pk, SA 5042, Australia
关键词
esophageal squamous cell carcinoma; immunohistochemistry; methylation; TIMP3;
D O I
10.3748/wjg.14.203
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To measure the frequency of DNA methylation of the tissue inhibitor of metalloproteinase 3 (TIMP3) promoter and relate this to any change of gene expression in esophageal squamous cell carcinoma in patients from a region of high incidence in China. METHODS: Cancer cell lines were treated with or without the demethylating reagent 5-aza-2'-deoxycytidine. Methylation of the TIMP3 promoter was assessed in three regions by melt curve analysis and its expression was assessed by real-time RT-PCR. Tumors and proximal resection margins were obtained from 64 patients with esophageal squamous cell carcinoma from a region of high incidence in China. Methylation was assessed by melt curve analysis and expression by immunohistochemistry. RESULTS: Methylation in one of the three promoter regions assessed correlated with gene silencing in esophageal cell lines. A degree of methylation of TIMP3 was found in only four esophageal squamous cell carcinomas, and partial loss of TIMP3 protein expression in just one. CONCLUSION: Methylation and loss of expression of TIMP3 occurs infrequently in esophageal squamous cell carcinoma in a region of high incidence in China. (c) 2008 WJG. All rights reserved.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 38 条
[1]   Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors [J].
Ahonen, M ;
Poukkula, M ;
Baker, AH ;
Kashiwagi, M ;
Nagase, H ;
Eriksson, JE ;
Kähäri, VM .
ONCOGENE, 2003, 22 (14) :2121-2134
[2]  
AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817
[3]  
Bachman KE, 1999, CANCER RES, V59, P798
[4]   Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3 [J].
Bian, JH ;
Wang, YL ;
Smith, MR ;
Kim, H ;
Jacobs, C ;
Jackman, J ;
Kung, HF ;
Colburn, NH ;
Sun, Y .
CARCINOGENESIS, 1996, 17 (09) :1805-1811
[5]  
Brock MV, 2003, CLIN CANCER RES, V9, P2912
[6]   CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus [J].
Chang, Moon-Sung ;
Uozaki, Hiroshi ;
Chong, Ja-Mun ;
Ushiku, Tetsuo ;
Sakuma, Kazuya ;
Ishikawa, Shunpei ;
Hino, Rumi ;
Barua, Rita Rani ;
Iwasaki, Yoshiaki ;
Arai, Kuniyoshi ;
Fujii, Hideki ;
Nagai, Hideo ;
Fukayama, Masashi .
CLINICAL CANCER RESEARCH, 2006, 12 (10) :2995-3002
[7]   Methylation of APC, TIMP3, and TERT:: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation [J].
Clément, G ;
Braunschweig, R ;
Pasquier, N ;
Bosman, FT ;
Benhattar, J .
JOURNAL OF PATHOLOGY, 2006, 208 (01) :100-107
[8]   Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers [J].
Curran, S ;
Dundas, SR ;
Buxton, J ;
Leeman, MF ;
Ramsay, R ;
Murray, GI .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8229-8234
[9]   Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma:: Loss of expression correlates with poor prognosis [J].
Darnton, SJ ;
Hardie, LJ ;
Muc, RS ;
Wild, CP ;
Casson, AG .
INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (03) :351-358
[10]   Tissue inhibitor of metalloproteinase-3 induces apoptosis in prostate cancer cells and confers increased sensitivity to paclitaxel [J].
Deng, Xiyun ;
Bhagat, Sunita ;
Dong, Zhong ;
Mullins, Chadwick ;
Chinni, Sreenivasa Rao ;
Cher, Michael .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (18) :3267-3273